The future of the five-member girl group has been somewhat up in the air since leaving ADOR, a subsidiary of the South Korean mega-label HYBE, and leveling allegations of misconduct and mistreatment.

The battle between NewJeans and Ador and its parent company Hybe has intensified. Today, the K-pop group has revealed they’re changing their name to NJZ. They’ve also announced that they’ll ...

K-pop girl group NewJeans has revealed a new name for itself — NJZ — amid an ongoing legal battle with its label Ador. The quintet, consisting of Minji, Hanni, Danielle, Haerin and Hyein ...

The ongoing legal battle between NewJeans and their label ADOR is set to reach the courtroom for the first time next month. The Seoul Central District Court has scheduled the first hearing for ...

Sky News understands that Mr Zahawi, who has assembled a portfolio of roles since leaving frontline politics, will be named on Thursday as chair of the advisory board of Ador Diagnostics.

NewJeans' record label Ador has filed an injunction against the girl group in an attempt to stop them inking brand deals without their consent. The K-pop label said such activities could ...

And while the Altamonte Springs/Longwood border in no way resembles the quaint village of Saint-Geniès-des-Mourgues, the breads and pastries being crafted out of J'adore's kitchen in the Sand ...

The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...

If you are a fan of NewJeans (or NJZ now), you might be more than a little perplexed by all the recent events between the quintet and their first record label and management company, ADOR, a ...

Hanni also added that NJZ are intending to move forward and hope that their ongoing disputes with ADOR and HYPE will not be “the focus” of their career. In a press release regarding their ...

J&J said that about a third of adults will not respond to oral antidepressants alone. Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team.

Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...